As shelter-in-place orders drag on and the U.S. economy limps through the second quarter, investors, economists and politicians are asking important questions about what the post-outbreak economy will look like and how quickly the U.S. can replace the 26 million jobs it has lost in 2020.
Many Americans have been turning to cannabis to help them get through the stress of the COVID-19 outbreak, but there’s a strong case that U.S. marijuana legalization could help the economy recover as well.
Throughout the downturn, states like Michigan and California have deemed cannabis an “essential” product not subject to mandatory shutdowns. In fact, cannabis sales have skyrocketed in many of those locations.
Yet these businesses deemed to be essential by local and state governments are still illegal on a federal level. On Tuesday, DataTrek Research co-founder Jessica Rabe said the cannabis industry has several unique characteristics that could be extremely beneficial to an economy trying to get back on its feet.
In states in which marijuana is decriminalized, the industry has provided a job boom. For example, there are now as many cannabis workers in Nevada as there are bartenders, according to Leafly. Massachusetts has more cannabis workers than hair stylists and cosmetologists.
Economics Of Cannabis
Rabe estimates that legalizing marijuana on a federal level could add 170,000 jobs in the states of New York and New Jersey alone.
At the same time, many of these jobs are relatively high-paying and do not require even a college degree, she said. According to Glassdoor, the median salary for a legal marijuana job in the U.S. in January 2019 was $58,500.
Rabe said she wouldn’t be surprised to see more politicians turn to cannabis as the U.S. recovers from the outbreak.
“Legalizing sales of recreational marijuana could add tens of thousands of high paying, quality jobs at all education levels in states across the US. Aside from tax revenue, this is another reason large US states like New York that have been deeply affected by the virus may try to speed up legalization,” she said.
One way for investors to play the boom in cannabis demand in legalized states and a potential outcry for U.S. federal legalization heading into the 2020 election is to buy U.S. multistate operators.
Earlier this month, Alan Brochstein, author of the 420 Investor and founding partner of New Cannabis Ventures, told Benzinga that MSOs Cresco Labs Inc CRLBF, Curaleaf Holdings Inc CURLF, Green Thumb Industries Inc GTBIF and Trulieve Cannabis Corp TCNNF are the safest bets for cannabis investors in the current environment.
Do you agree with this take? Email email@example.com with your thoughts.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.